There are no adequate or well controlled studies in pregnant women and nursing mothers. As with other nasal corticosteroid preparations, MODEXA nasal spray suspension should be used in pregnant women, nursing mothers or women of childbearing age only if the potential benefit justifies the potential risk to the mother, fetus, or infant. Infants born of mothers who received corticosteroids during pregnancy should be observed carefully for hypoadrenalism.